Cargando…

Dinutuximab beta in the treatment of high-risk neuroblastoma: A follow-up of a case series in Bratislava

Despite therapeutic advances, high-risk neuroblastoma is still associated with a poor long-term prognosis. Immunotherapy with the anti-GD2 antibody dinutuximab beta has recently been added to the standard of care for patients with high-risk neuroblastoma in our center in Bratislava, and our initial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Achbergerová, Monika, Hederová, Stanislava, Hrašková, Andrea, Kolenová, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	6200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797591/ https://www.ncbi.nlm.nih.gov/pubmed/35089239 http://dx.doi.org/10.1097/MD.0000000000028716

Ejemplares similares

Dinutuximab beta for neuroblastoma
Publicado: (2020)

Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
por: Spasov, Neofit, et al.
Publicado: (2021)

Nivolumab and dinutuximab beta in two patients with refractory neuroblastoma
por: Ehlert, Karoline, et al.
Publicado: (2020)

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Clinical Presentation and Management of a Dinutuximab Beta Extravasation in a Patient with Neuroblastoma
por: Launspach, Michael, et al.
Publicado: (2021)

Dinutuximab Beta in Children with High-Risk Neuroblastoma: Experience from a Single Center in Croatia
por: Giljević, Jasminka Stepan, et al.
Publicado: (2022)

Neuroblastoma, Body Mass Index, and Survival: A Retrospective Analysis
por: Small, Annabel G., et al.
Publicado: (2015)

Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with Neuroblastoma
por: Balaguer, Julia, et al.
Publicado: (2022)

Management of tumor rupture and abdominal compartment syndrome in an infant with bilateral high risk stage 4 neuroblastoma: A case report
por: Lode, Holger N., et al.
Publicado: (2019)

Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma
por: Liu, Qinglin, et al.
Publicado: (2020)

Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance
por: Barone, Giuseppe, et al.
Publicado: (2021)

Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy
por: Keyel, Michelle E, et al.
Publicado: (2018)

Longitudinal follow-up of muscle echotexture in infants with congenital muscular torticollis
por: Hu, Ching-Fang, et al.
Publicado: (2017)

Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based Immunotherapy
por: Cicek, Filiz, et al.
Publicado: (2020)

Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
por: Olgun, Nur, et al.
Publicado: (2022)

Case report: neonatal giant forehead hemangiopericytoma with a 5-year follow-up
por: Peng, AiJun, et al.
Publicado: (2019)

Complication rates following all-epiphyseal ACL reconstructions in skeletally immature patients: A retrospective case series study
por: Saad, Lydia, et al.
Publicado: (2021)

Treatment of High-Risk Neuroblastoma with Dinutuximab and Chemotherapy Administered in all Cycles of Induction
por: Cupit-Link, Margaret, et al.
Publicado: (2023)

Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials
por: Wieczorek, Aleksandra, et al.
Publicado: (2022)

Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)
por: Ladenstein, Ruth, et al.
Publicado: (2020)

The effect of insoles on symptomatic flatfoot in preschool-aged children: A prospective 1-year follow-up study
por: Chen, Kun-Chung, et al.
Publicado: (2019)

Long term follow-up in a patient with prune-belly syndrome – a care compliant case report
por: Cornel, Aldea, et al.
Publicado: (2019)

Outcome of Preterm Infants With Postnatal Cytomegalovirus Infection via Breast Milk: A Two-Year Prospective Follow-Up Study
por: Jim, Wai-Tim, et al.
Publicado: (2015)

Congenital Kyphoscoliosis in Monozygotic Twins: Ten-Year Follow-up Treated by Posterior Vertebral Column Resection (PVCR): A Case Report
por: Chang, Dong-Gune, et al.
Publicado: (2016)

Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings—Real-World Data
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Modified decision-making rule supported by scheduled telephone follow-up reduces head computed tomography utilization in children with mild traumatic brain injury: A cohort study
por: Zou, Liqun, et al.
Publicado: (2020)

Pediatric hyperimmunoglobulin E syndrome: A case series of 4 children in China
por: Fan, Huifeng, et al.
Publicado: (2018)

Inflammatory bowel diseases: a burden in pediatrics: Case series and a review of the literature
por: Mărginean, Cristina Oana, et al.
Publicado: (2017)

Chemotherapeutics Used for High-Risk Neuroblastoma Therapy Improve the Efficacy of Anti-GD2 Antibody Dinutuximab Beta in Preclinical Spheroid Models
por: Troschke-Meurer, Sascha, et al.
Publicado: (2023)

Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse
por: Flaadt, Tim, et al.
Publicado: (2023)

GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma
por: Zirngibl, Felix, et al.
Publicado: (2021)

The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD(2) Antibody Dinutuximab Beta
por: Siebert, Nikolai, et al.
Publicado: (2022)

Malignant sacrococcygeal germ cell tumors in children in Taiwan: A retrospective single-center case series
por: Chen, Shih-Hsiang, et al.
Publicado: (2021)

Misdiagnosed anomalous left coronary artery from the pulmonary artery as endocardial fibroelastosis in infancy: A case series
por: Ma, Fan, et al.
Publicado: (2017)

Non-Hodgkin lymphoma, diagnostic, and prognostic particularities in children – a series of case reports and a review of the literature (CARE compliant)
por: Mărginean, Cristina Oana, et al.
Publicado: (2018)

Unmeasurable capillary C-reactive protein as one of the diagnostic clues of severe hematological pathologies in children in primary settings: Case series
por: Piteková, Barbora, et al.
Publicado: (2023)

COVID-19 positive cases in a pediatric surgery department from Romania: Case series from 2 years of pandemics
por: Filip, Florin, et al.
Publicado: (2023)

Cord Blood PRF1 Methylation Patterns and Risk of Lower Respiratory Tract Infections in Infants: Findings From the Ulm Birth Cohort
por: Elgizouli, Magdeldin, et al.
Publicado: (2015)

Multi-system inflammatory syndrome in children during the coronavirus disease 2019 in Saudi Arabia: Clinical perspective from a case series
por: Asseri, Ali A., et al.
Publicado: (2021)

Reduced central line infection rates in children with leukemia following caregiver training: A quality improvement study
por: Lo Vecchio, Andrea, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f3rdc10ov3o4cfi113gc3mslgo